1-3 of 3
Alessia Montagnoli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PHA767491, a Dual Cdc7/CDK9 Inhibitor, with Potential to Target Both Proliferation and Survival in CLL.

Alessandro Natoni, PhD, Amjad Hayat, MBBS, MRCP, MRCPath, PhD, Alessia Montagnoli, PhD, Grace Callagy, MB, PhD, MRCPI, FRCPath, Afshin Samali, PhD, Corrado Santocanale, PhD, Michael C O'Dwyer, MD, FRCPI, FRCPath
Journal: Blood
Blood (2009) 114 (22): 2366.
https://doi.org/10.1182/blood.V114.22.2366.2366
Published: 2009
Journal Articles

Targeting Cdc7 Kinase in Multiple Myeloma.

Mark R.E. Coyne, MBBCh, BAO, MRCPI, Seán Naughton, Patrick J Hayden, MD, MRCPath, Alessia Montagnoli, PhD, Michael E O'Dwyer, MD, FRCPI, FRCPath, Corrado Santocanale, PhD
Journal: Blood
Blood (2009) 114 (22): 3847.
https://doi.org/10.1182/blood.V114.22.3847.3847
Published: 2009
Journal Articles

Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma

Roberto Chiarle, Leo M. Budel, Jeffrey Skolnik, Glauco Frizzera, Marco Chilosi, Alessandra Corato, Gianni Pizzolo, Jory Magidson, Alessia Montagnoli, Michele Pagano, Brigitte Maes, Christine De Wolf-Peeters, Giorgio Inghirami
Journal: Blood
Blood (2000) 95 (2): 619–626.
https://doi.org/10.1182/blood.V95.2.619
Published: 2000